Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mallmann

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Zentralblatt Fur Gynakologie|June 4, 1999
[Practical value of immunotherapy in gynecologic oncology]P Mallmann
Hybridoma|April 1, 1995
Tumor vaccinationP Mallmann
Hybridoma|October 1, 1993
Autologous tumor-cell vaccination and lymphokine-activated tumor-infiltrating lymphocytes (LAK-TIL)P Mallmann
Geburtshilfe Und Frauenheilkunde|November 1, 1994
[Immunotherapy in gynecologic oncology]P Mallmann
Der Internist|October 19, 2006
[Breast cancer: adjuvant therapy with trastuzumab: herceptin adjuvant (HERA) Trial Study, B-31- and N9831-Study]P Mallmann
Infection|January 1, 1992
Immunological effects of cefodizime in patients undergoing antineoplastic chemotherapyP Mallmann, P Brühl
Archives of Gynecology and Obstetrics|January 1, 1995
[Immunology and oncology]P Mallmann, H Weitzel
Zentralblatt Fur Gynakologie|January 1, 1991
[Effect of tamoxifen on parameters of cell-mediated immunity in postmenopausal patients with breast carcinoma]P Mallmann, D Krebs
Onkologie|June 1, 1989
[The effect of immunotherapy with thymopentin on the parameters of cellular immunity and the clinical course of gynecologic tumor patients]P Mallmann, D Krebs
Geburtshilfe Und Frauenheilkunde|April 12, 2016
Recommendations for the Diagnosis and Treatment of Endometrial Cancer, Update 2013G Emons, P Mallmann,
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Zentralblatt Fur Gynakologie|June 4, 1999
[Practical value of immunotherapy in gynecologic oncology]P Mallmann
Hybridoma|April 1, 1995
Tumor vaccinationP Mallmann
Hybridoma|October 1, 1993
Autologous tumor-cell vaccination and lymphokine-activated tumor-infiltrating lymphocytes (LAK-TIL)P Mallmann
Geburtshilfe Und Frauenheilkunde|November 1, 1994
[Immunotherapy in gynecologic oncology]P Mallmann
Der Internist|October 19, 2006
[Breast cancer: adjuvant therapy with trastuzumab: herceptin adjuvant (HERA) Trial Study, B-31- and N9831-Study]P Mallmann
Infection|January 1, 1992
Immunological effects of cefodizime in patients undergoing antineoplastic chemotherapyP Mallmann, P Brühl
Archives of Gynecology and Obstetrics|January 1, 1995
[Immunology and oncology]P Mallmann, H Weitzel
Zentralblatt Fur Gynakologie|January 1, 1991
[Effect of tamoxifen on parameters of cell-mediated immunity in postmenopausal patients with breast carcinoma]P Mallmann, D Krebs
Onkologie|June 1, 1989
[The effect of immunotherapy with thymopentin on the parameters of cellular immunity and the clinical course of gynecologic tumor patients]P Mallmann, D Krebs
Geburtshilfe Und Frauenheilkunde|April 12, 2016
Recommendations for the Diagnosis and Treatment of Endometrial Cancer, Update 2013G Emons, P Mallmann,
Pageof 12